Seasonal variation in the non-specific effects of BCG vaccination on neonatal mortality: three randomised controlled trials in Guinea-Bissau.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
2020
Historique:
received: 27 07 2019
revised: 11 09 2019
accepted: 15 09 2019
entrez: 24 3 2020
pubmed: 24 3 2020
medline: 24 3 2020
Statut: epublish

Résumé

The BCG vaccine protects non-specifically against other diseases than tuberculosis. Three randomised controlled trials of early BCG in Guinea-Bissau found a 38% reduction in all-cause neonatal mortality. Little is known about the underlying mechanisms. In Guinea-Bissau, prevalent infectious diseases display distinct seasonality. Revisiting the three trials (>6500 infants) comparing early BCG versus no early BCG in low weight infants on all-cause neonatal mortality over 12 consecutive years, we explored the seasonal variation in BCG's effect on mortality. In a subgroup of participants, adaptive and innate cytokine responses were measured 4 weeks after randomisation. Consistently over the course of the three trials and 12 years, the effect of BCG on all-cause neonatal mortality was particularly beneficial when administered in November to January, coincident with peaking malaria infections. During these months, BCG was also associated with stronger proinflammatory responses to heterologous challenge. Recent studies have suggested a protective effect of BCG against malaria. BCG may also ameliorate immune-compromising fatal effects of placental malaria in the newborn.

Identifiants

pubmed: 32201619
doi: 10.1136/bmjgh-2019-001873
pii: bmjgh-2019-001873
pmc: PMC7059430
doi:

Substances chimiques

BCG Vaccine 0

Banques de données

ClinicalTrials.gov
['NCT00146302', 'NCT00625482']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Pagination

e001873

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Vaccine. 2005 Jan 26;23(10):1251-7
pubmed: 15652667
Malar J. 2010 Jan 14;9:16
pubmed: 20074331
Lancet. 2019 Aug 31;394(10200):757-779
pubmed: 31257127
Eur J Clin Nutr. 2005 Sep;59(9):1081-9
pubmed: 16015266
PLoS One. 2016 Jun 17;11(6):e0157163
pubmed: 27315120
Am J Trop Med Hyg. 2018 Feb;98(2):534-542
pubmed: 29210351
PLoS One. 2013 Jul 04;8(7):e66115
pubmed: 23861742
J Pediatric Infect Dis Soc. 2019 Feb 3;:
pubmed: 30715451
Science. 2016 Apr 22;352(6284):aaf1098
pubmed: 27102489
PLoS One. 2013 Oct 03;8(10):e77334
pubmed: 24098583
BMJ. 2016 Oct 13;355:i5170
pubmed: 27737834
J Infect Dis. 2006 Jan 1;193(1):146-54
pubmed: 16323143
Malar J. 2014 Jul 11;13:271
pubmed: 25015559
Malar J. 2010 Nov 06;9:313
pubmed: 21054891
Bull World Health Organ. 2002;80(7):562-8
pubmed: 12163920
J Infect Dis. 2010 Sep 1;202 Suppl:S239-42
pubmed: 20684710
Eur J Immunol. 2010 Apr;40(4):1062-72
pubmed: 20039298
Cell Rep. 2016 Dec 6;17(10):2562-2571
pubmed: 27926861
Acta Paediatr. 2007 Oct;96(10):1526-30
pubmed: 17850399
Vaccine. 2001 Nov 12;20(3-4):468-74
pubmed: 11672911
BMJ. 1996 Oct 19;313(7063):969-74
pubmed: 8892416
Open Forum Infect Dis. 2017 Feb 11;4(1):ofx022
pubmed: 28480292
BMJ. 1993 Aug 14;307(6901):417-20
pubmed: 8374453
Malar J. 2016 Oct 7;15(1):497
pubmed: 27717402
Lancet Infect Dis. 2007 Feb;7(2):93-104
pubmed: 17251080
Acta Paediatr. 2003;92(2):170-6
pubmed: 12710642
Vaccine. 2016 Oct 17;34(44):5298-5305
pubmed: 27622301
Hum Vaccin Immunother. 2018;14(10):2434-2442
pubmed: 29293396
BMC Med. 2017 May 10;15(1):98
pubmed: 28486979
J Infect Dis. 2019 Jan 29;219(4):624-632
pubmed: 30239767
PLoS One. 2011;6(11):e27516
pubmed: 22096588
J Pediatric Infect Dis Soc. 2019 Jul 1;8(3):213-220
pubmed: 29635419
BMC Immunol. 2008 Oct 17;9:59
pubmed: 18928527
BMC Med. 2018 Nov 2;16(1):198
pubmed: 30384846
Clin Exp Immunol. 2009 Dec;158(3):287-93
pubmed: 19758375
Am J Respir Crit Care Med. 2012 Jan 15;185(2):213-22
pubmed: 22071384
Ann Nutr Metab. 2017;70(3):179-183
pubmed: 28301842
Pediatr Infect Dis J. 2012 Mar;31(3):306-8
pubmed: 22189537
Pediatr Infect Dis J. 2013 Jan;32(1):e14-9
pubmed: 22914561
Clin Exp Immunol. 2003 Sep;133(3):414-21
pubmed: 12930369
Int J Epidemiol. 2005 Jun;34(3):540-7
pubmed: 15659474
Trop Doct. 2008 Apr;38(2):73-6
pubmed: 18453488
Eur J Clin Microbiol Infect Dis. 2018 Jan;37(1):29-41
pubmed: 28890996
Clin Infect Dis. 2012 Sep;55(5):672-8
pubmed: 22610927
Nat Commun. 2019 Feb 20;10(1):874
pubmed: 30787276
J Infect Dis. 2015 Mar 15;211(6):956-67
pubmed: 25210141
Trop Med Int Health. 2017 Jul;22(7):846-856
pubmed: 28464403
Vaccine. 2015 Apr 21;33(17):2056-65
pubmed: 25765965
Stat Med. 2013 Jul 20;32(16):2859-74
pubmed: 23212926
PLoS Med. 2009 Jul;6(7):e1000116
pubmed: 19636353
Pediatr Infect Dis J. 2019 Feb;38(2):198-202
pubmed: 30256314
Expert Rev Vaccines. 2018 Jun;17(6):547-554
pubmed: 29882438
J Infect Dis. 2011 Jul 15;204(2):245-52
pubmed: 21673035
J Infect Dis. 2014 May 15;209(10):1653-62
pubmed: 24325967
J Infect Dis. 2002 Sep 1;186(5):593-7
pubmed: 12195345
Clin Infect Dis. 2017 Oct 1;65(7):1183-1190
pubmed: 29579158
J Infect Dis. 2018 May 5;217(11):1798-1808
pubmed: 29415180
FEMS Microbiol Rev. 2008 Aug;32(5):821-41
pubmed: 18616602
Vaccine. 2007 Aug 21;25(34):6313-20
pubmed: 17643559
J Immunol. 2005 Feb 1;174(3):1738-45
pubmed: 15661939
J Immunol. 1999 Aug 15;163(4):2249-55
pubmed: 10438968
PLoS Pathog. 2014 Oct 30;10(10):e1004485
pubmed: 25356988
Clin Chem. 2005 Oct;51(10):1854-66
pubmed: 16081507
Microbiol Insights. 2018 Feb 13;11:1178636118758651
pubmed: 29467579
Am J Epidemiol. 1997 Nov 15;146(10):826-31
pubmed: 9384203
Infect Immun. 2013 Aug;81(8):2686-96
pubmed: 23690399
BMC Infect Dis. 2012 Jan 14;12:6
pubmed: 22243970
PLoS One. 2014 Jul 01;9(7):e101167
pubmed: 24984039
Influenza Other Respir Viruses. 2016 Sep;10(5):386-93
pubmed: 27012372

Auteurs

Kristoffer Jarlov Jensen (KJ)

Bandim Health Project, University of Southern Denmark, Copenhagen, Denmark.
Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.

Sofie Biering-Sørensen (S)

Bandim Health Project, University of Southern Denmark, Copenhagen, Denmark.

Johan Ursing (J)

Department of Infectious Diseases, Danderyd University Hospital, Stockholm, Sweden.
Department of Clinical Sciences, Karolinska Institute, Stockholm, Sweden.

Poul-Erik Lund Kofoed (PL)

Department of Pediatrics, Kolding Hospital, Kolding, Denmark.
Bandim Health Project, INDEPTH Network, Bissau, Guinea-Bissau.

Peter Aaby (P)

Bandim Health Project, University of Southern Denmark, Copenhagen, Denmark.
Bandim Health Project, INDEPTH Network, Bissau, Guinea-Bissau.

Christine Stabell Benn (CS)

Bandim Health Project, University of Southern Denmark, Copenhagen, Denmark.
OPEN, Institute of Clinical Research, University of Southern Denmark, Odense, Syddanmark, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH